Congenital malformations in experimental diabetic pregnancy: Aetiology and antioxidative treatment. Minireview based on a doctoral thesis

Upsala Journal of Medical Sciences

Volumn 102, Issue 2, 1997, Pages 61-98

  Simán, Martin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ANIMAL; CONGENITAL MALFORMATION; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HUMAN; LIPID PEROXIDATION; PREGNANCY; PREGNANCY DIABETES MELLITUS; RAT; REVIEW;

ABNORMALITIES; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HUMANS; LIPID PEROXIDATION; PREGNANCY; PREGNANCY IN DIABETICS; RATS; REACTIVE OXYGEN SPECIES;

EID: 0030631116     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009739709178933     Document Type: Article

References (237)

1. Aerts L., Holemans K. & van Assche F.A.: Maternal diabetes during pregnancy: consequences for the offspring. Diab Metab Rev 6:147-167, 1990.
2. Akashi M., Akazawa S., Akazawa M., Trocino R., Hashimoto M., Maeda Y., Yamamoto H., Kawasaki E., Takino H., Yokota A. & et a.l.: Effects of insulin and myo-inositol on embryo growth and development during early organogenesis in streptozocin-induced diabetic rats. Diabetes 40:1574-1579, 1991.
3. Ansari N.H. & Srivastava S.K.: Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis. Biochem Biophys Res Commun 168:939-943, 1990.
4. Baker L., Piddington R., Goldman A., Egler J. & Moehring J.: Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33:593-596, 1990.
5. Baynes J.W.: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991.
6. Becerra J.E., Khoury M.J., Cordero J.F. & Erickson J.D.: Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9, 1990.
7. Bendich A., Machlin L.J., Scandurra O., Burton G.W. & Wayner D.D.M.: The antioxidant role of vitamin C. Adv Free Rad Biol Med 2:419-444, 1986.
8. Beyer R.E.: The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and Coenzyme Q. J Bioenerg Biomembr 26:349-358, 1994.
9. Beyer-Mears A. & Cruz E.: Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes 34:15-21, 1985.
10. Björkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L. & Henriksson P.: The antioxidant butylated hydroxytoluene protects against atherosclerosis. 11:15-22, 1991.
11. Bockman D.E. & Kirby M.L.: Dependence of thymus development on derivatives of the neural crest. Science 223:498-500, 1984.
12. Bockman D.E., Redmond ME. & Kirby M.L.: Altered development of pharyngeal arch vessels after neural crest ablation. Ann NY Acad Sci 588:296-304, 1990.
13. Bolton J.L. & Thompson J.A.: Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formations by hepatic and pulmonary microsomes. Drug Metab Dispos 19:467-472, 1991.
14. Bond J., Green C., Donaldson P. & Kistler J.: Liquefaction of cortical tissue in diabetic and galactosemic rat lenses defined by confocal laser scanning microscopy. Invest Ophthalmol Vis Sci 37:1557-1565, 1996.
15. Bondy C.A. & Lightman S.L.: Developmental and physiological pattern of aldose reductase mRNA expression in lens and retina. Mol Endocrinol 3:1417-1425, 1989.
16. Bondy C.A., Lightman S.L. & Lightman S.L.: Developmental and physiological regulation of aldose reductase mRNA expression in renal medulla. Mol Endocrinol 3:1409-1416, 1989.
17. Bonet B., Viana M. & Herrera E.: The prevention of the teratogenic effects of diabetes by vitamin E is dose dependent. Diabetes 46 (Suppl 1):259A (Abstract), 1997.
18. Broekhuizen M.L., Bouman H.G., Mast F., Mulder P.G., Gittenberger D.G.A. & Wladimiroff J.W.: Hemodynamic changes in HH stage 34 chick embryos after treatment with all-transretinoic acid. Pediatr Res 38:342-348, 1995.
19. Brown W.D., Johnson A.R. & O'Halloran M.W.: The effect of the level of dietary fat on the toxicity of phenolic antioxidants. Aust J Exp Biol 37:533-548, 1959.
20. Buchanan T.A., Denno K.M., Sipos G.F. & Sadler T.W.: Diabetic teratogenesis. In vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43:656-660, 1994.
21. Buchanan T.A. & Freinkel N.: Fuel-mediated teratogenesis: symmetric growth retardation in the rat fetus at term after a circumscribed exposure to D-mannose during organogenesis. Am J Obstet Gynecol 158:663-669, 1988.
22. Cameron N.E., Cotter M.A. & Maxfield E.K.: Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36:299-304, 1993.
23. Carone D., Loverro G., Greco P., Capuano F. & Selvaggi L.: Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 51:103-109, 1993.
24. Cederberg J. & Eriksson U.J.: Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology: In press 1997.
25. Ceriello A., Bortolotti N., Falleti E., Taboga C., Tonutti L., Crescentini A., Motz E., Lizzio S., Russo A. & Bartoli E.: Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 20:194-197, 1997.
26. Chen M.S., Hutchinson M.L., Pecoraro R.E., Lee W.Y. & Labbe R.F.: Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 32:1078-1081, 1983.
27. Cheng H.M. & Gonzalez R.G.: The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. Metabolism 35 (Suppl 1):10-14, 1986.
28. Chylack L.T. & Kinoshita J.H.: A biochemical evaluation of a cataract induced in a high-glucose medium. Invest Ophthalmol 8:401-412, 1969.
29. Cockroft D.L. & Coppola P.T.: Teratogenic effect of excess glucose on head-fold rat embryos in culture. Teratology 16:141-146, 1977.
30. Cotter M.A., Love A., Watt M.J., Cameron N.B. & Dines K.C.: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38:1285-1294, 1995.
31. Crabbe M.J.C., Goode D. & Wolff S.P.: Aldose reductase: black sheep or skeleton in the cupboard? Nat Struct Biol 3:659-660, 1996.
32. Cross C.E., Halliwell B., Borish E.T., Pryor W.A., Ames B.N., Saul R.L., McCord J.M. & Harman D.: Davis conference; Oxygen radicals and human disease. Ann Int Med 107:526-545, 1987.
33. Danielson K., Simán C.M., Danielson B., Naeser P. & Eriksson U.J.: Diabetes-induced developmental changes in the offspring of a malformation-prone rat strain. Manuscript, 1997.
34. Davis W.L., Crawford L.A., Cooper O.J., Farmer G.R., Thomas D.L. & Freeman B.L.: Ethanol induces the generation of reactive free radicals by neural crest cells in vitro. J Craniofac Genet Dev Biol 10:277-293, 1990.
35. Duclos A.J., Haddad E.K. & Baines M.G.: Presence of activated macrophages in a murine model of early embryo loss. Am J Reprod Immunol 33:354-366, 1995.
36. Duncan J.M.: On puerperal diabetes. Trans Obstet London 24:256-285, 1882.
37. El-Hage S. & Singh S.M.: Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev Genet 11:149-159, 1990.
38. Endo A.: Teratogenesis in diabetic mice treated with alloxan prior to conception. Arch Environ Health 12:492-500, 1966.
39. Eriksson R.S.M., Thunberg L. & Eriksson U.J.: Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats. Diabetes 38:764-772, 1989.
40. Eriksson U.J.: Diabetes in pregnancy: a study of complications in the offspring of the rat. Thesis. Acta Universitatis Upsaliensis: Uppsala, 1981.
41. Eriksson U.J.: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37:365-374, 1988.
42. Eriksson U.J., Bone A.J., Turnbull D.M. & Baird J.D.: Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effect on maternal metabolism and fetal outcome. Acta Endocrinol 120:800-810, 1989.
43. Eriksson U.J. & Borg L.A.H.: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991.
44. Eriksson U.J. & Borg L.A.H.: Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993.
45. Eriksson U.J., Borg L.A.H., Cagliero E., Hagay Z., Weiss Y. & Groner Y.: Increased activity of superoxide dismutase in transgenic mouse embryos protects from glucose-induced dysmorphogenesis. Manuscript, 1997.
46. Eriksson U.J., Brolin S.E. & Naeser P.: Influence of sorbitol accumulation on growth and development of embryos cultured in elevated levels of glucose and fructose. Diab Res 11:27-32, 1989.
47. Eriksson U.J., Dahlström E., Larsson K.S. & Hellerström C: Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31:1-6, 1982.
48. Eriksson U.J., den Bieman M., Prins J.B. & van Zutphen L.F.M.: Differences in susceptibility for diabetes-induced malformations in separated rat colonies of common origin. Proc 4th FELASA Symp, Lyon, France, p 53-57, 1990.
49. Eriksson U.J., Naeser P. & Brolin S.E.: Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes 35:1356-1363, 1986.
50. Eriksson U.J. & Simán C.M.: Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in the offspring. Diabetes 45:1497-1502, 1996.
51. Eriksson U.J. & Swenne I.: Diabetes in pregnancy: fetal macrosomia, hyperinsulinism, and islet hyperplasia in the offspring of rats subjected to temporary protein-energy malnutrition early in life. Pediatr Res 34:791-795, 1993.
52. Eriksson U.J., Wentzel P., Minhas H.S. & Thornalley P.J.: High 3-deoxyglucosone (3-DG) concentration in malformed rat embryos in vitro. Diabetologia 40, suppl 1:A 233 (Abstract), 1997.
53. Evans H.B.: On the relations between fertility and nutrition. J Metab Res. 1:319-350, 1922.
54. Ferencz C., Rubin J.D., McCarter R.J. & Clark E.B.: Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 41:319-326, 1990.
55. Fisher B. & Bavister B.D.: Oxygen tension in the oviduct and uterus of rhesus monkeys, hamster and rabbits. J Reprod Fertil 99:673-679, 1993.
56. Fisher E., McLennan S.V., Tada H., Heffernan S., Yue D.K. & Turtle J.R.: Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts. Diabetes 40:371-376, 1991.
57. Forsberg H., Borg L.A.H., Cagliero E. & Eriksson U.J.: Altered levels of scavenging enzymes in embryos subjected to a diabetic environment. Free Rad Res 24:451-459, 1996.
58. Forsberg H., Eriksson U.J., Melefors Ö. & Welsh N.: Beta-hydroxybutyrate increases reactive oxygen species in late but not in early postimplantation embryonic cells in vitro. Diabetes: In press 1997.
59. Frawley J.P., Kohn P.E., Kay J.H. & Calandra J.C.: Progress report on mutigeneration reproduction studies in rats fed butylated hydroxy toluene (BHT). Food Cosmet Toxicol 3:377-386, 1965.
60. Frei B., England L. & Ames B.N.: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86:6377-6381, 1989.
61. Frei B., Stocker R., England L. & Ames B.N.: Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 264:155-163, 1990.
62. Freinkel N.: Banting lecture 1980; Of pregnancy and progeny. Diabetes 29:1023-1035, 1980.
63. Fridovich I. : Free Radicals in Biology. Academic Press: New York, 1976.
64. Funaki K. & Mikamo K.: Developmental-stage-dependent teratogenic effects of maternal spontaneous diabetes in the Chinese hamster. Diabetes 32:637-643, 1983.
65. Gabbay K.H.: The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831-836, 1973.
66. Garner P.: Type I diabetes mellitus and pregnancy. Lancet 346:157-161, 1995.
67. Giavini E., Broccia M.L., Prati M., Roversi G.D. & Vismara C: Effects of streptozotocin-induced diabetes on fetal development of the rat. Teratology 34:81-88, 1986.
68. Giavini E. & Prati M.: Morphogenesis of diabetes-induced congenital cataract in the rat. Acta Anat (Basel) 137:132-136, 1990.
69. Giavini E., Prati M. & Roversi G.: Congenital malformations in the offspring of diabetic rats: exerimental study on the influence of the diet composition and magnesium intake. Biol Neonate 57:207-217, 1990.
70. Giavini G., Broccia M.L., Prati M., Roversi G.D. & Vismara C.: Cataractogenic effects of streptozotocin-induccd diabetes in rat fetuses. Acta Embryol Morphol Exper N.S. 8:481-486, 1987.
71. Gilbert S.F. : Developmental Biology. 4 ed. Sinauer Associates Inc: Sunderland, Massachusetts, 1994.
72. Ginter E.: Ascorbic acid in cholesterol metabolism and in detoxification of xenobiotic substances: problem of optimum vitamin C intake. Nutrition 5:369-374, 1989.
73. Goldenberg H. & Schweinzer E.: Transport of vitamin C in animal and human cells. J Bioenerg Biomembr 26:359-367, 1994.
74. Goldman A.S., Baker L., Piddington R., Marx B., Herold R. & Egler J.: Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci U S A 82:8227-8231, 1985.
75. Gosseye S., Golaire M.C., Verellen G., van Lierde M. & Claus D.: Association of bilateral renal agenesis and Di George syndrome in an infant of a diabetic mother. Helv Paediat Acta 37:471-474, 1982.
76. 2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos. Diabetes 41:1644-1650, 1992.
77. 1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39:225-231, 1989.
78. Gutteridge J.M. & Halliwell B.: Iron toxicity and oxygen radicals. Baillieres Clin Haematol 2:195-256, 1989.
79. Gutteridge J.M.C. & Halliwell B.: The measurement and mechanism of lipid peroxidation in biological systems. TIBS 15:129-135, 1990.
80. Guyton K.Z., Thompson J.A. & Kensler T.W.: Role of quinone methide in the in vitro toxicity of the skin tumor promotor butylated hydroxytoluene hydroperoxide. Chem Res Toxicol 6:731-738, 1993.
81. Hagay Z.J., Weiss Y., Zusman I., Peled -Kamar M., Reece E.A., Eriksson U.J. & Groner Y.: Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc Superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041, 1995.
82. Hall B.K.: The induction of neural crest-derived cartilage and bone by embryonic epithelia: an analysis of the mode of action of an epithelial-mesenchymal interaction. J Embryol Exp Morph 64:305-320, 1981.
83. Hall B.K. & Hörstadius S.: The Neural Crest. Oxford University Press: New York, 1988.
84. Hall B.K. & Tremaine R.: Ability of neural crest cells from the embryonic chick to differentiate into cartilage before their migration away from the neural tube. Anat Rec 194:469-476, 1979.
85. Hanson U., Persson B. & Thunell S.: Relationship between haemoglobin A. in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 33:100-104, 1990.
86. Harding J.J. & Crabbe J.C.: The lens: development, protein metabolism and cataract. In Daveson, H. (ed). The Eye. Academic Press: New York, p. 207-367, 1984.
87. Harrison D.H.T., Bohren K.M. & Gabbay K.H.: In reply - Some are not in the family. Nat Struct Biol 3:660-661, 1996.
88. Harwood HJ., Greene Y.J. & Stacpoole P.W.: Inhibition of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate. J Biol Chem 261:7127-7135, 1986.
89. Hashimoto M., Akazawa S., Akazawa M., Akashi M., Yamamoto H., Maeda Y., Yamaguchi Y., Yamasaki H., Tahara D., Nakanishi T. & Nagataki S.: Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 33:597-602, 1990.
90. Hod M., Star S., Passonneau J., Unterman T.G. & Freinkel N.: Glucose-induced dysmorphogenesis in the cultured rat conceptus: prevention by supplementation with myoinositol. Israel J Med Sci 26:541-544, 1990.
91. Hod M., Star S., Passonneau J.V., Unterman T.G. & Freinkel N.: Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Comm 140:974-980, 1986.
92. Hogers B., DeRuiter M.C., Gittenberger de Groot A.C. & Poelmann R.E.: Unilateral vitelline vein ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo. Circ Res 80:473-481, 1997.
93. Hook E.B., Healy K.M., Niles A.M. & Skalko R.G.: Letter: Vitamin E: teratogen or antiteratogen? Lancet 1:861, 1974.
94. Hyatt G.A. & Beebe D.C.: Regulation of lens cell growth and polarity by embryonic-specific growth factor and by inhibitors of lens cell proliferation and differentiation. Development 117:701-709, 1993.
95. Ingermann R.L., Stankova L. & Bigley R.H.: Role of monosaccharide transporter in vitamin C uptake by placental membrane vesicles. Am J Physiol 250:C637-C641, 1986.
96. Ingold K.U.: Inhibition of the autoxidation of organic substances in the liquid phase. Chem Res 61:563-589, 1961.
97. Janssen P.A., Rothman I. & Schwartz S.M.: Congenital malformations in newborns of woman with established and gestational diabetes in Washington State, 1984-91. Paediat Perinat Epidemol 10:52-63, 1996.
98. Johnson A.R. & Hewgil F.R.: The effect of the antioxidants, butylated hydroxy anisole, butylated hydroxy toluene and propyl gallate on growth, liver and serum lipids and serum sodium levels of the rat. Aust J Exp Biol 39:353-360, 1961.
99. Juhl B., Klein F. & Christiansen J.S.: Decrease of transcapillary escape of albumin during treatment with vitamin C in IDDM patients with retinopathy. Diabetologia 38 (Suppl 1):A245 (Abstract), 1996.
100. Kador P.F. & Kinoshita J.H.: Diabetic and galactosaemic cataracts, (ed). 1984 Human cataract formation (Ciba Foundation symposium 106). Pitman: London, p. 110-131, 1984.
101. Kador P.F., Kinoshita J.H., Brittain D.R., Mirrlees D.J., Sennitt C.M. & Stribling D.: Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors. Biochem J 240:233-237, 1986.
102. Kalter H.: Diabetes and spontaneous abortion: a historical review. Am J Obstet Gynecol 156:1243-1253, 1987.
103. Kappus H. & Diplock A.T.: Tolerance and safety of vitamin E: a toxicological position report. Free Radic Biol Med 13:55-74, 1992.
104. Katsaras J., Stinson R.H., Davis J.H. & Kendall E.J.: Location of two antioxidants in oriented model membranes. Small-angel x-ray diffraction study. Biophys J 59:645-653, 1991.
105. Kilic F., Mitton K., Dzialoszynski T., Sanford S.E. & Trevithick J.R.: Modelling cortical cataractogenesis 14: Reduction in lens damage in diabetic rats by a dietary regimen combining vitamins C and E and beta-carotene. Dev Ophthalmol 26:63-71, 1994.
106. Kimmerle R., Zaß R.-P., Cupisti S., Somville T., Bender R., Pawlowski B. & Berger M.: Pregnancies in women with diabetic nephropathy: long term outcome for mother and child. Diabetologia 38:227-235, 1995.
107. Kinoshita J.H.: Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol 13:713-724, 1974.
108. Kinoshita J.H., Merola L.O. & Tung B.: Changes in cation permeability in the galactose-exposed rabbit lens. Exp Eye Res 7:80-90, 1968.
109. Kirby M.L., Gale T.F. & Stewart D.E.: Neural crest cells contribute to aorticopulmonary septation. Science 220:1059-1061, 1983.
110. Kirby M.L., Turnage K.L. & Hays B.M.: Characterization of conotruncal malformations following ablation of "cardiac" nerual crest. Anat Rec 213:87-93, 1985.
111. Kirby M.L. & Waldo K.L.: Neural crest and cardiovascular pattering. Circ Res 77:211-215, 1995.
112. Kitzmiller J.L., Gavin L.A., Gin G.D., Jovanovic-Peterson L., Main E.K. & Zigrang W.D.: Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 265:731-736, 1991.
113. Krasavage W.J. & Terhaar C.J.: d-alpha-Tocopheryl poly(ethylene glycol) 1000 succinate. Acute toxicity, subchronic feeding, reproduction, and teratologic studies in the rat. J Agric Food Chem 25:273-278, 1977.
114. Kucera J,: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70, 1971.
115. Kunisaki M., Umeda F., Inoguchi T., Watanabe J. & Nawata H.: Effects of vitamin E administration on platelet function in diabetes mellitus. Diab Res 14:37-42, 1990.
116. Kurihara Y., Kurihara H., Maemura K., Kuwaki T., Kumada M. & Yazaki Y.: Impaired development of the thyroid and thymus in endothelin-1 knockout mice. J Cardiovasc Pharmacol 26 (Suppl 3):S13-S16, 1995.
117. Lazarow A., Kim J.N. & Wells L.J.: Birth weight and fetal mortality in pregnant subdiabetic rats. Diabetes 9:114-117, 1960.
118. Lee A.T. & Eriksson U.J.: Embryos exposed to high glucose in vitro show congenital malformations and decreased frequency of DNA mutations. Diabetologia 38 (Suppl 1):A281 (Abstract), 1995.
119. Lee A.T., Plump A., DeSimone C., Cerami A. & Bucala R.: A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos. Diabetes 44:20-24, 1995.
120. Lee A.Y., Chung S.K. & Chung S.S.: Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci U S A 92:2780-2784, 1995.
121. Linklater H.A., Dzialoszynski T., McLeod H.L., Sanford S.E. & Trevithick J.R.: Modelling cortical cataractogenesis VIII: Effects of butylated hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic rats. Exp Eye Res 43:305-313, 1986.
122. Loeken M.R.: Vitamin E may exacerbate the embryopathic effects of diabetic pregnancy. Diabetes 46 (Suppl 1):259A (Abstract), 1997.
123. Lowy C., Beard R.W. & Goldschmidt J.: Congenital malformations in babies of diabetic mothers. Diabetic Med 3:458-462, 1986.
124. Lowy C., Beard R.W. & Goldschmidt J.: The UK diabetic pregnancy survey. Acta Endocrinol Suppl 277:86-89, 1986.
125. Mackler B., Grace R., Haynes B., Bargman G.J. & Shepard T.H.: Studies of mitochondrial energy systems during embryogenesis in the rat. Arch Biochem Biophys 158:662-666, 1973.
126. Maclin L.J. : Vitamin E. A Comprehensive Treatise. Marcel Dekker: New York, 1980.
127. Malkinson A.M. & Beer D.S.: Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation. J Natl Cancer Inst 73:925-933, 1984.
128. Many A., Lazebnik N. & Hill L.M.: The underlying cause of polyhydramnios determines prematurity. Prenat Diagn 16:55-57, 1996.
129. Martin M.M. & Hurley L.S.: Effect of large amounts of vitamin E during pregnancy and lactation. Am J Clin Nutr 30:1629-1637, 1977.
130. Martinez-Frias M.L.: Epidemiological analysis of outcomes of pregnancy in diabetic mothers: Identification of the most characteristic and most frequent congenital anomalies. Am J Med Gen 51:108-113, 1994.
131. McCormick D.L., May C.M., Thomas C.F. & Detrisac C.J.: Anticarcinogenic and hepatotoxic interactions betweeen retinyl acetate and butylated hydroxytoluene in rats. Cancer Res 46:5264-5269, 1986.
132. McLennan S., Yue D.K., Fisher E., Capogreco C., Heffeman S., Ross G.R. & Turtle J.R.: Deficiency of ascorbic acid in experimental diabetes. Relationship with collagen and polyol pathway abnormalities. Diabetes 37:359-361, 1988.
133. Miller E., Hare J.W., Cloherty J.P., Dunn P.J., Gleason R.E., Soeldner J.S. & Kitzmiller J.L.: Elevated maternal hemoglobin Ale in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334, 1981.
134. Mills J.L., Baker L. & Goldman A.S.: Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28:292-293, 1979.
135. Mills J.L., Knopp R.H., Simpson J.L., Jovanovic-Peterson L., Metzger B.E., Holmes L.B., Aarons J.H., Brown Z., Reed G.F., Bieber F.R., Van Alien M., Holzman I., Ober C., Peterson C.M., Withiam M.J., Duckies A., Mueller-Heubach E., Polk B.F. & National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study Group: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671-676, 1988.
136. Minetti M., Forte T., Soriani M., Quaresima V., Menditto A. & Ferrari M.: Iron-induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation. No spintrapping evidence for the hydroxyl radical in iron-overloaded plasma. Biochem J 282:459-465, 1992.
137. Miodovnik M., Mimouni F., Dignan P.S., Berk M.A., Ballard J.L., Siddiqi T.A., Khoury J. & Tsang R.C.: Major malformations in infants of IDDM women. Vasculopathy and early first-trimester poor glycemic control. Diab Care 11:713-718, 1988.
138. Mitchell J.A. & Van Kainen B.R.: Effects of alcohol on intrauterine oxygen tension in the rat. Alcohol Clin Exp Res 16:308-310, 1993.
139. Mooradian A.D.: Effect of ascorbate and dehydroascorbate on tissue uptake of glucose. Diabetes 36:1001-1004, 1987.
140. Morishima M., Ando M. & Takao A.: Visceroatrial heterotaxy syndrome in the NOD mouse with special reference to atrial situs. Teratology 44:91-100, 1991.
141. Muzikova E. & Clark D.A.: Is spontaneous resorption in the DBA/2-mated CBA/J mouse due to a defect in "seed" or in "soil"? Am J Reprod Immunol 33:81-85, 1995.
142. Männer J., Seidl W. & Steding G.: Correlation between the embryonic head flexures and cardiac development. An experimental study in chick embryos. Anat Embryol 188:269-285, 1993.
143. Mølsted-Pedersen L.: Pregnancy and diabetes. A survey. Acta Endocrinol 238:13-19, 1980.
144. Mølsted-Pedersen L. & Kühl C: Obstetrical management in diabetic pregnancy: the Copenhagen experience. Diabetologia 29:13-16, 1986.
145. 3H]-glucose uptake and sorbitol metabolism of bovine retina in vitro. J Diab Compl 9:31-36, 1995.
146. New D.A.T.: Whole embryo culture and the study of mammalian embryos during embryogenesis. Biol Rev 53:81-122, 1978.
147. Nielsen G.L. & Nielsen P.H.: Outcome of 328 pregnancies in 205 woman with insulin-dependent diabetes mellitus in the county of nothern Jutland from 1976 to 1990. Eur J Obstet Gyncol Reprod Biol 50:33-38, 1993.
148. Niki E.: Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 44:227-253, 1987.
149. Niki E.: Vitamin C as an antioxidant. World Rev Nutr Diet 64:1-30, 1991.
150. Nishikimi M. & Vagi K.: Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 54:1203S-1208S, 1991.
151. Noden D.M., Poelmann R.E. & Gittenberger-de Groot A.C.: Cell origins and tissue boundaries during outflow tract development. Trends Cardiovasc Med 5:69-75, 1995.
152. Norkus E.P., Bassi J.A. & Rosso P.: Maternal hyperglycemia and its effect on the placental transport of ascorbic acid. Pediatr Res 16:746-750, 1982.
153. Nourooz-Zadeh J., Tajaddini-Sarmadi J. & Wolff S.P.: Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403-409, 1994.
154. Novak R.W. & Robinson H.B.: Coincident DiGeorge anomaly and renal agenesis and its relation to maternal diabetes. Am J Med Gen 50:311-312, 1994.
155. Oberley L.W.: Free radicals and diabetes. Free Rad Biol Med 5:113-124, 1988.
156. Ogata E.S., Sabbagha R., Metzger B.E., Phelps R.L., Depp R. & Freinkel N.: Serial ultrasonography to assess evolving fetal macrosomia. JAMA 243:2405-2408, 1980.
157. Packer J.E., Slater T.F. & Willson R.L.: Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 278:737-738, 1979.
158. Palumbo G., Fagone S., Russo I., Foddai I. & Rugolo S.: Detection of late fetal and neonatal malformations in infants of diabetic mothers. Diab Nutr Metab 3 (Suppl 2):79-80, 1990.
159. Pampfer S., de Hertogh R., Vanderheyden I., Michiels B. & Vercheval M.: Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39:471-476, 1990.
160. Pampfer S., Vanderheyden I., Wuu Y.D., Baufays L., Maillet O. & De Hertogh R.: Possible role for TNF-alpha in early embryopathy associated with maternal diabetes in the rat. Diabetes 44:531-536, 1995.
161. Parke D.V. & Lewis D.F.V.: Safety aspects of food preservatives. Food Addit Contam 9:561-577, 1992.
162. Pedersen J.F. & Mølsted-Pedersen L.: Early growth retardation in diabetic pregnancy. Br Med J 4:1-5, 1979.
163. Persson B. & Hanson U.: Fetal size at birth in relation to quality of blood glucose control in pregnancies complicated by pregestational diabetes mellirus. Br J Obstet Gynecol 103:427-433, 1996.
164. Petersen MB., Pedersen S.A., Greisen G., Pedersen J.F. & Moisted P.L.: Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J (Clin Res Ed) 296:598-600, 1988.
165. Pinter E., Reece E.A., Leranth C.Z., Garcia-Segura M., Hobbins J.C. & Mahoney M.J.: Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol 155:691-702, 1986.
166. Pitkin R.M. & Van Orden D.E.: Fetal effects of maternal streptozotocin-diabetes. Endocrinology 94:1247-1253, 1974.
167. Potashnik Y., Ayalon N., Khamaisi M., Wiznitzer A. & Bashan N.: Lipoic acid treatment decreases neural tube defects in fetuses of diabetic rats. Diabetologia 40 (Suppl 1):A585 (Abstract), 1997.
168. Powell C.J. & Connolly A.K.: The site specificity and sensitivity of the rat liver to butylated hydroxytoluene-induced damage. Toxicol Appl Pharmacol 108:67-77, 1991.
169. Ramos-Arroyo M.A., Rodrigues-Pinilla E. & Cordero J.F.: Maternal diabetes: The risk for specific birth defects. Eur J Epidemol 8:503-508, 1992.
170. Reece A.E. & Wu Y.K.: Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant. Am J Obstet Gyncol 176:790-798, 1997.
171. Reece E.A., Khandelwal M., Wu Y.K. & Borenstein M.: Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gyncol 176:536-539, 1997.
172. Reece E.A., Wiznitzer A., Homko C.J., Hagay Z. & Wu Y.K.: Synchronization of the factors critical for diabetic teratogenesis: an in vitro model. Am J Obstet Gynecol 174:1284-1288, 1996.
173. Reece E.A., Wu Y.K., Wiznitzer A., Homko C., Yao J., Borenstein M. & Sloskey G.: Dietary polyunsaturated fatty acid prevents malformations in offspring of diabetic rats. Am J Obstet Gynecol 175:818-823, 1996.
174. Rosenn B., Miodovnik M., Combs C.A., Khoury J. & Siddiqi T.A.: Glycemic thresholds for spontaneous abortions and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 84:515-520, 1994.
175. Roversi G.D. & Giavini E.: Damage to the crystalline lens in infants of diabetic mothers: a pathology so far neglected? Ophthalmologica 204:175-178, 1992.
176. Sadler T.W. : Langman's Medical Embryology. Williams & Wilkins: Baltimore, 1985.
177. Sadler T.W. & Horton W.E.J.: Effects of maternal diabetes on early embryogenesis: the role of insulin and insulin therapy. Diabetes 32:1070-1074, 1983.
178. Sadler T.W., Phillips L.S., Balkan W. & Goldstein S.: Sometomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes 35:861-865, 1986.
179. Sakamaki H., Akazawa S., Ishibashi M., Izumino K., Abiru N., Kondo H., Takino H., Yamasaki H., Yamaguchi Y., Kondo T. & Nagataki S.: Diabetes-induced embryopathy and glutathione-dependent antioxidant system. Diabetes 46 (Suppl 1):88A (Abstract), 1997.
180. Sato Y., Hotta N., Sakmoto N., Matsuoka S., Oshishi N. & Yagi K.: Lipid peroxide levels of plasma of diabetic patients. Biochem Med 21:104-107, 1979.
181. Schoenfeld A., Erman A., Warchaizer S., Ovadia J., Bonner J. & Hod M.: Yolk sac concentration of prostaglandin E2 in diabetic pregnancy: further clues to the etiology of diabetic embryopathy. Prostaglandins 50:121-126, 1995.
182. Sevanian A., Davies K.J.A. & Hochstein P.: Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54:11295-11345, 1991.
183. Siegenberg D., Baynes R.D., Bothwell T.H., Macfarlane B.J., Lamparelli R.D., Car N.G., MacPhail P., Schmidt U., Tal A. & Mayet F.: Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption. Am J Clin Nutr 53:537-541, 1991.
184. Simán C.M. & Eriksson U.J.: Effect of butylated hydroxytoluene on α-tocopherol content in liver and adipose tissue of rats. Toxicol Lett 87:103-108, 1996.
185. Simán C.M. & Eriksson U.J.: Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia In press, 1997.
186. Simán C.M. & Eriksson U.J.: Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061, 1997.
187. Simán C.M., Gittenberger-de Groot A.C., Wisse B. & Eriksson U.J.: Neural crest related malformations in offspring of diabetic rats decrease with vitamin E treatment. Manscript,
188. Simán C.M., Naeser P. & Eriksson U.J.: Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats. Acta Ophthalmol Copenh 71:629-636, 1993.
189. Sivan E., Reece E.A., Wu Y.K., Homko C.J., Polansky M. & Borenstein M.: Dietary vitamin E prophylaxis and diabetic embryopathy: Morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799, 1996.
190. Sokol R.J., Heubi J.E., Jannaccone S., Bove K.E. & Balistreri W.F.: Mechanism causing vitamin E deficiency during chronic childhood cholestasis. Gastroenterology 85:1172-1182, 1983.
191. Solomon F.: Embryomegaly and increased fetal mortality in pregnant rats with mild alloxan diabetes. Diabetes 8:45-50, 1959.
192. Som S., Basu S., Mukherjee D., Deb S., Choudhury P.R., Mukherjee S., Chatterjee S.N. & Chatterjee I.E.: Ascorbic acid metabolism in diabetes mellitus. Metabolism 30:572-577, 1981.
193. Srivastava S.K. & Ansari N.H.: Prevention of sugar-induced cataractogenesis in rats by butylated hydroxytoluene. Diabetes 37:1505-1508, 1988.
194. Srivastava S.K., Ansari N.H. & Bhatnagar A.: Sugar induced cataractogenesis: a paradigm of oxidative tissue pathology? Lens Eye Toxic Res 7:161-171, 1990.
195. Stokes J.D. & Scudder C.L.: The effect of butylated hydroxyanisole and butylated hydroxytoluene on behavioral development of mice. Dev Psychbiol 7:343-350, 1974.
196. Stribling D. & Kador P.F.: Aldose reductase, enzyme or artefact? Prog Clin Biol Res 232:309-316, 1987.
197. Strieleman P.J., Connors M.A. & Metzger B.E.: Phosphoinositide metabolism in the developing conceptus. Effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes 41:989-997, 1992.
198. Strieleman P.J. & Metzger B.E.: Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus: a role in dysmorphogenesis? Teratology 48:267-278, 1993.
199. Styrud J. & Eriksson U.J.: Effects of D-glucose and b-hydroxybutyric acid on the in vitro development of (pre)chondrocytes from embryos of normal and diabetic rats. Acta Endocrinol (Copenh) 122:487-498, 1990.
200. Styrud J. & Eriksson U.J.: In vitro effects of glucose and growth factors on limb bud and mandibular arch chondrocytes maintained at various serum concentrations. Teratology 44: 65-75, 1991.
201. Styrud J., Thunberg L., Nybacka O. & Eriksson U.J.: Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37:343-353, 1995.
202. Styrud J., Unger E. & Eriksson U.J.: Metabolism in vitro of cartilage proteoglycans in rat (pre)chondrocytes from different embryonic regions. Ups J Med Sci 95:31-44, 1990.
203. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanathan M., Mohan R. & Shanmugasundaram K.R.: Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 90:255-260, 1996.
204. Suzuki N., Svensson K. & Eriksson U.J.: High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia 39:401-411, 1996.
205. Tanaka T., Oishi S. & Takahashi O.: Three generation toxicity study of butylated hydroxytoluene administered to mice. Toxicol Lett 66:295-304, 1993.
206. Tatsua M., Mikuni T. & Taniguchi H.: Protective effect of butylated hydroxytoluene against induction of gastric cancer by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 32:253-254, 1983.
207. Terao J., Magadan R.A., Brueggemann G. & King M.M.: Methods of extraction and highperformance liquid Chromatographic analysis of butylated hydroxytoluene from the tissues and serum of rats. Anal Biochem 151:445-454, 1985.
208. The Diabetes Control and Complications Trial Research Group: Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 174:1343-1353, 1996.
209. Traber M.G.: Determinants of plasma vitamin E concentrations. Free Radic Biol Med 16:229-239, 1994.
210. Trevithick J.R., Linklater H.A., Mitton K.P., Dzialoszynski T. & Sanford S.E.: Modeling cortical cataractogenesis: IX. Activity of vitamin E and esters in preventing cataracts and gamma-crystallin leakage from lenses in diabetic rats. Ann N Y Acad Sci 570:358-371, 1989.
211. Trocino R.A., Akazawa S., Ishibashi M., Matsumoto K., Matsuo H., Yamamoto H., Goto S., Urata Y., Kondo T. & Nagataki S.: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998, 1995.
212. Tsai E.G., Hirsch I.B., Brunzell J.D. & Chait A.: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43:1010-1014, 1994.
213. van Heyningen R.: Formation of polyols by the lens of rat with 'sugar' cataract. Nature 184:194-195, 1959.
214. Varma S.D. & Kinoshita J.H.: The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res 19:577-582, 1974.
215. Vera J.C., Rivas C.I., Fischbarg J. & Golde D.W.: Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 364:79-82, 1993.
216. Viana M., Herrera E. & Bonet B.: Teratogenic effects of diabetes mellitus in the rat. Prevention with vitamin E. Diabetologia 39:1041-1046, 1996.
217. Vorhees C.V., Butcher R.E., Brunner R.L. & Sobotka T.J.: Developmental neurobehavioural toxicity of butylated hydroxytoluene in rats. Food Cosmet Toxicol 19:153-162, 1981.
218. Weigensberg M.J., Garcia-Palmer F.-J. & Freinkel N.: Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. Diabetes 39:575-582, 1990.
219. Wentzel P. & Eriksson U.J.: High glucose levels and cyclooxygenase inhibitors cause embryonic dysmorphogenesis in vivo. Diabetes 46:259A (Abstract), 1997.
220. Wentzel P., Thunberg L. & Eriksson U.J.: Teratogenic effect of diabetic serum is prevented by supplementation of Superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14, 1997.
221. WHO: Evaluation of certain food additives and contaminants. 44th Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 859:5-8, 1995.
222. Williams G.M., Tanaka T. & Maeura Y.: Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis 7:1043-1050, 1986.
223. Williams J.W.: The clinical significance of glycosuria in pregnant women. Am J Med Sci 137:1-26, 1909.
224. Wilson T.A., Blethen S.L., Vallone A., Alenick D.S., Nolan P., Katz A., Amorillo T.P., Goldmuntz E., Emanuel B.S. & Driscoll D.A.: DiGeorge anomaly with renal agenesis in infants of mothers with diabetes. Am J Med Gen 47:1078-1082, 1993.
225. Witschi H., Williamson D. & Lock S.: Enhancement of urethane tumorigenesis in mouse lung by butylated hydroxytoluene. J Natl Cancer Inst 58:301-305, 1977.
226. Wolff S.P. & Crabbe M.J.: Low apparent aldose reductase activity produced by monosaccharide autoxidation. Biochem J 226:625-630, 1985.
227. Yamamoto Y., Brodsky M.H., Baker J.C. & Ames B.N.: Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal Biochem 160:7-13, 1987.
228. Yang X., Borg L.A.H. & Eriksson U.J.: Altered mitochondrial morphology of rat embryos in diabetic pregnancy. Anal Rec 241:255-267, 1995.
229. Yang X., Borg L.A.H. & Eriksson U.J.: Altered metabolism and Superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272:E173-E180, 1997.
230. Yang X., Borg L.A.H., Simán C.M. & Eriksson U.J.: Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos. Manuscript, 1997.
231. Yang X., Welsh N., Welsh M. & Eriksson U.J.: Maternal diabetes is teratogenic without damaging embryonic mitochondrial DNA. Diabetologia 38 (Suppl 1):A209 (Abstract), 1996.
232. Yew M.S.: Effect of streptozotocin diabetes on tissue ascorbic acid and dehydroascorbic acid. Horm Metabol Res 15:158, 1983.
233. Yoshida H., Yusin M., Ren I., Kuhlenkamp J., Hirano T., Stolz A. & Kaplowitz N.: Identification, purification, and immunochemical characterization of a tocopherol-binding protein in rat liver cytosol. J Lipid Res 33:343-350, 1992.
234. Yoshioka T., Motoyama H., Yamasaki F. & Noma J.: Lipid peroxidation and its protective mechanism during developmental stage in rat. Acta Obst Gynaec Jpn 34:966-970, 1982.
235. Young I.S., Tate S., Lightbody J.H., McMaster D. & Trimble E.R.: The effects of desferrioxamine and ascorbate on oxidative stess in the streptozotocin diabetic rat. Free Radic Biol Med 18:833-840, 1995.
236. Young I.S., Tomey J.J. & Trimble E.R.: The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Rad Biol Med 13:41-46, 1992.
237. Zalani S., Rajalakshmi R. & Parekh L.J.: Ascorbic acid concentration of human fetal tissues in relation to fetal size and gestational age. Br J Nutr 61:601-606, 1989.